All Stories

  1. The Beneficial Effects of QIAPI 1® against Pentavalent Arsenic-Induced Lung Toxicity: A Hypothetical Model for SARS CoV2-Induced Lung Toxicity
  2. Complex Treatment and Prosthetic Rehabilitation of an Acquired Maxillofacial Defect with Tumor Invasion: Brief Report
  3. Statistical Review of the Suicide Attempts Rates Committed on Polish Railway Tracks between the Years 2013-2016
  4. The Efficacy of Melanin Precursor QIAPI 1© Against Age-related Macular Degeneration (AMD): A Case Report
  5. Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link
  6. The Links between Cardiovascular Diseases and Alzheimer's Disease
  7. The Dawn of Mitophagy: What Do We Know by Now?
  8. Suicide and Suicide Attempts in the Elderly Patients: An Epidemiological Analysis of Risk Factors and Prevention
  9. The Long-Term Effect of Medically Enhancing Melanin Intrinsic Bioenergetics Capacity in Prematurity
  10. Growth factors produced inside the reproductive system
  11. Synthesis and Cytotoxic Activity of Azine Derivatives of 6-Hydroxyxanthanodiene
  12. The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer
  13. A comprehensive new understanding of DDD and their proposed therapies and studies
  14. New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents
  15. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target
  16. Medicinal glues in surgery
  17. Anatomy of the posterior perforated substance.
  18. The Modulation of Beneficial and/or Harmful Effects of Free Oxygen Radicals in the Context of Molecular Mechanisms Regarding Drug – PART I
  19. Publisher Correction: Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities
  20. Comparing the Treatment of Congenital Spine Deformity Using Freehand Techniques In Vivo and 3D-Printed Templates In Vitro (Prospective–Retrospective Single-Center Analytical Single-Cohort Study)
  21. The Role of Melanin to Dissociate Oxygen from Water to Treat Retinopathy of Prematurity
  22. A Novel Heterocyclic System Based on Natural Epoxyalantolactone
  23. Extracellular vesicles in cancer nanomedicine
  24. Implications of nanotechnology for the treatment of cancer: Recent advances
  25. Increased Pain Sensitivity in Obese Patients After Lung Cancer Surgery
  26. Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy
  27. How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein Interactions
  28. Application of Acyzol in the Context of Zinc Deficiency and Perspectives
  29. Assessment of Psychosocial Functioning of Mothers of Children with Diabetes Mellitus Compared to Mothers of Healthy Children
  30. Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases
  31. Biological Transformations controlled by the Mind as a Potential Treatment of DDD
  32. Preface
  33. Alzheimer’s Disease – Future Therapy Based on Dendrimers
  34. Pharmacological Approaches Targeting Brain Cell Survival in the Context of Neurodegeneration and Potential Treatment Strategies
  35. Quality of Life and Social Support in Women with Urinary Incontinence
  36. New Therapeutic Property of Dimebon as a Neuroprotective Agent
  37. Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease
  38. Late-life Depression and Alzheimer Disease: A Potential Synergy of the Underlying Mechanisms
  39. Natural compounds can be used for Alzheimer's and Parkinson's diseases treatment
  40. Applications of Multi-Target Computer-Aided Methodologies in Molecular Design of CNS Drugs
  41. Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications
  42. Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule
  43. Classification (Agonist/Antagonist) and Regression “Structure-Activity” Models of Drug Interaction with 5-HT6
  44. The Possibility of an Infectious Etiology of Alzheimer Disease
  45. The dopaminergic dysfunction and altered working memory performance of aging mice lacking gamma-synuclein gene
  46. Extracts of Physalis peruviana Protect Astrocytic Cells Under Oxidative Stress With Rotenone
  47. Urotensin II: Molecular Mechanisms of Biological Activity
  48. Corrigendum to “Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention” [Pharmacol. Res. 129 (2018) 216–226]
  49. Sleep Disorders Associated With Alzheimer's Disease: A Perspective
  50. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
  51. Correction to: Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder
  52. Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus
  53. Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia
  54. Pharmacological Aspects of Neuro-Immune Interactions
  55. Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention
  56. Anthocyanins and its biological & therapeutic characters
  57. Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder
  58. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease
  59. Portacaval shunting causes differential mitochondrial superoxide production in brain regions
  60. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  61. Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus
  62. PeMtb: A Database of MHC Antigenic Peptide of Mycobacterium tuberculosis
  63. Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets
  64. Medicinal Plants as Protective Strategies Against Parkinson's Disease
  65. Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases
  66. Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
  67. Nanotechnology for Alzheimer Disease
  68. Conditioned Medium of Human Adipose Mesenchymal Stem Cells Increases Wound Closure and Protects Human Astrocytes Following Scratch Assay In Vitro
  69. Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer’s Disease
  70. A Systematic in-silico Analysis of Helicobacter pylori Pathogenic Islands for Identification of Novel Drug Target Candidates
  71. Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice
  72. Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities
  73. Bioremediation of bioplastics
  74. Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach
  75. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
  76. Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
  77. Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis
  78. Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players
  79. Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay
  80. Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders
  81. Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions
  82. Erratum: Biogenic synthesis of Zinc oxide nanostructures from Nigella sativa seed: Prospective role as food packaging material inhibiting broad-spectrum quorum sensing and biofilm
  83. Mineraxin, beneficial bioproduct in menopuase
  84. Neuroinflammation in Alzheimer's Disease
  85. Biogenic synthesis of Zinc oxide nanostructures from Nigella sativa seed: Prospective role as food packaging material inhibiting broad-spectrum quorum sensing and biofilm
  86. Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease
  87. Therapeutic Potentials of Triterpenes in Diabetes and its Associated Complications
  88. Sol-gel synthesis of thorn-like ZnO nanoparticles endorsing mechanical stirring effect and their antimicrobial activities: Potential role as nano-antibiotics
  89. Can Erythrocyte Catalase Regulate Blood Pressure?
  90. Meet Our Section Editor:
  91. Cardiovascular drugs and triazole based kinase inhibitors as a new strategies for the treatment of Alzheimer disease
  92. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents
  93. Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
  94. Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
  95. Antifertility Activity of Lac (Laccifer lacca Kerr.) in Female Wistar Rat Model
  96. A synopsis on the linkage between age-related dementias and vascular disorders
  97. Novel Therapeutic Strategies for Dementia
  98. Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
  99. Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection
  100. Molecular Mechanisms of Drug Photodegradation and Photosensitization
  101. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
  102. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine
  103. Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome
  104. Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches
  105. Relationship between chronic disturbance of 2,3-diphosphoglycerate metabolism in erythrocytes and Alzheimer disease
  106. Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound
  107. Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis
  108. Meet Our Editor:
  109. The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
  110. Smoking and PTSD
  111. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
  112. Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice
  113. Biological Activities of QIAPI 1 as a Melanin Precursor and Its Therapeutic Effects in Wistar Rats Exposed to Arsenic Poisoning
  114. Ca2+-Myristoyl Switch in Neuronal Calcium Sensor-1: A Role of C-Terminal Segment
  115. Glutenase and collagenase activities of wheat cysteine protease Triticain-α: Feasibility for enzymatic therapy assays
  116. Beyond Mitochondria, What Would be the Energy Source of the Cell?
  117. Preface:
  118. Medicinal Plants in Management of Type 2 Diabetes and Neurodegenerative Disorders
  119. Design of a hybrid nanostructure based on fullerene C60 and biologically active substance for modeling physiological properties of compounds
  120. Differential Up-Regulation of Ammonia Detoxifying Enzymes in Cerebral Cortex, Cerebellum, Hippocampus, Striatum and Liver in Hyperammonemia
  121. Dimebon Attenuates the Aβ-Induced Mitochondrial Permeabilization
  122. Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies
  123. Impact of Amyloid β25-35 on Membrane Stability, Energy Metabolism, and Antioxidant Enzymes in Erythrocytes
  124. Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
  125. Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
  126. Implication of the Nutritional and Nonnutritional Factors in the Context of Preservation of Cognitive Performance in Patients With Dementia/Depression and Alzheimer Disease
  127. Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion
  128. Age-Related Defects in Erythrocyte 2,3-Diphosphoglycerate Metabolism in Dementia
  129. Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-βVaccine
  130. Antioxidant Status and Energy State of Erythrocytes in Alzheimer Dementia: Probing for Markers
  131. The Prevalence of Epilepsy in the Nakhichevan Autonomous Republic of Azerbaijan
  132. Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
  133. Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases